Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Fiets, E.

Search results

  • RSS Feed
(1 - 4 of 4)
Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX
Ham, J.; Meerten, E.; Fiets, E.; Mc Haaglanden, F.J.; Slingerland, M.; Graaf, W.T.A. van der; ... ; Beerepoot, L.V. 2018
Cetuximab in combination with methotrexate (MTX) as first-line treatment in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): A phase Ib randomized phase II study versus single agent MTX
Other
metadata only
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
Boon, E.; Boxtel, W. van; Buter, J.; Jong, R.J.B. de; Es, R.J.J. van; Bel, M.; ... ; Registry Histopathology Cytopathol 2018
Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands
Article / Letter to editor
open access
Late physical, psychological and social consequences of ipilimumab treatment in advanced melanoma
Boekhout, A.H.; Hauptmann, M.; Eertwegh, A.J.M. van den; Hospers, G.A.P.; Groot, J.W.B. de; Aarts, M.J.B.; ... ; Blank, C.U. 2017
Late physical, psychological and social consequences of ipilimumab treatment in advanced melanoma
Article / Letter to editor
metadata only
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Kelderman, S.; Heemskerk, B.; Tinteren, H. van; Brom, R.R.H. van den; Hospers, G.A.P.; Eertwegh, A.J.M. van den; ... ; Blank, C.U. 2014
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Article / Letter to editor
metadata only